Suppr超能文献

促性腺激素释放激素拮抗剂、米非司酮和来曲唑预防大鼠模型卵巢过度刺激综合征的效果。

Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model.

机构信息

Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.

出版信息

Reprod Biomed Online. 2021 Feb;42(2):291-300. doi: 10.1016/j.rbmo.2020.10.006. Epub 2020 Oct 14.

Abstract

RESEARCH QUESTION

Can luteolysis-targeted drugs, gonadotrophin-releasing hormone antagonist (GnRH-ant), mifepristone and letrozole, administered separately or in combination, prevent the progression of ovarian hyperstimulation syndrome (OHSS) in a rat model?

DESIGN

Thirty-six female Wistar rats were randomly divided into six groups, including control group (OHSS group, ovarian hyperstimulation-induced OHSS); GnRH-ant group (OHSS with GnRH-ant treatment); mifepristone group (OHSS with mifepristone treatment); letrozole group (OHSS with letrozole treatment); combination group (OHSS with GnRH-ant, mifepristone and letrozole treatment in combination). The main outcomes were the alterations in OHSS-related indices, including ovarian weight, vascular permeability, serum oestradiol and progesterone levels, corpus luteum proportion and diameter, ovarian vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), caspase-3 and cleaved caspase-3 levels.

RESULTS

No significant difference was found in body weight gain among the six groups. Compared with the control group, the OHSS group showed significant increases in all OHSS-related indices. GnRH-ant treatment showed decreases in vascular permeability, serum oestradiol level, corpus luteum diameter, ovarian VEGF /IL-6 mRNA levels, and increases in ovarian caspase-3 and cleaved caspase-3 levels. Mifepristone treatment demonstrated reduction in serum progesterone level and corpus luteum diameter, and elevation in ovarian caspase-3 and cleaved caspase-3 levels. Letrozole treatment displayed a decline in serum oestradiol level and corpus luteum diameter, and up-regulation in ovarian caspase-3 and cleaved caspase-3 levels. The combination treatment by GnRH-ant, mifepristone and letrozole showed enhanced synergistic effect on reducing OHSS-related indices.

CONCLUSIONS

GnRH-ant, mifepristone and letrozole are beneficial in preventing the progression of OHSS through different luteolytic mechanisms. Cocktail style treatment shows enhanced synergistic effect on preventing the progression of OHSS.

摘要

研究问题

单独或联合使用促黄体溶解靶向药物、促性腺激素释放激素拮抗剂(GnRH-ant)、米非司酮和来曲唑能否预防卵巢过度刺激综合征(OHSS)在大鼠模型中的进展?

设计

36 只雌性 Wistar 大鼠随机分为 6 组,包括对照组(OHSS 组,卵巢过度刺激诱导的 OHSS);GnRH-ant 组(用 GnRH-ant 治疗的 OHSS);米非司酮组(用米非司酮治疗的 OHSS);来曲唑组(用来曲唑治疗的 OHSS);联合组(用 GnRH-ant、米非司酮和来曲唑联合治疗的 OHSS)。主要结局指标为 OHSS 相关指标的变化,包括卵巢重量、血管通透性、血清雌二醇和孕酮水平、黄体比例和直径、卵巢血管内皮生长因子(VEGF)、白细胞介素 6(IL-6)、半胱天冬酶-3 和 cleaved caspase-3 水平。

结果

六组间体重增加无显著差异。与对照组相比,OHSS 组所有 OHSS 相关指标均显著增加。GnRH-ant 治疗可降低血管通透性、血清雌二醇水平、黄体直径、卵巢 VEGF/IL-6mRNA 水平,增加卵巢半胱天冬酶-3 和 cleaved caspase-3 水平。米非司酮治疗可降低血清孕酮水平和黄体直径,增加卵巢半胱天冬酶-3 和 cleaved caspase-3 水平。来曲唑治疗可降低血清雌二醇水平和黄体直径,上调卵巢半胱天冬酶-3 和 cleaved caspase-3 水平。GnRH-ant、米非司酮和来曲唑联合治疗对降低 OHSS 相关指标具有增强的协同作用。

结论

通过不同的黄体溶解机制,GnRH-ant、米非司酮和来曲唑均有助于预防 OHSS 的进展。鸡尾酒式治疗对预防 OHSS 的进展具有增强的协同作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验